Adbry
Active substance: Tralokinumab
INJECTION, SOLUTION · TRALOKINUMAB 300 mg/2mL
United StatesActive
Marketing holder: LEO Pharma Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TRALOKINUMAB · 300 mg/2mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12095-ff49-715d-beff-29df3da0a0ec,01a12095-ff4e-7673-8d67-c41baef38cd7;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 50222-350
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 50222-350 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 50222-350 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 50222-350 · Verified 2026-10-09 · open in source